JP2022549066A5 - - Google Patents
Info
- Publication number
- JP2022549066A5 JP2022549066A5 JP2022512736A JP2022512736A JP2022549066A5 JP 2022549066 A5 JP2022549066 A5 JP 2022549066A5 JP 2022512736 A JP2022512736 A JP 2022512736A JP 2022512736 A JP2022512736 A JP 2022512736A JP 2022549066 A5 JP2022549066 A5 JP 2022549066A5
- Authority
- JP
- Japan
- Prior art keywords
- cxcr2
- inhibitor
- at1r
- blocker
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019903606A AU2019903606A0 (en) | 2019-09-26 | Method and Compositions for the Treatment of Disease | |
| AU2019903606 | 2019-09-26 | ||
| PCT/AU2020/050987 WO2021056051A1 (en) | 2019-09-26 | 2020-09-18 | Method and composition for the treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022549066A JP2022549066A (ja) | 2022-11-24 |
| JP2022549066A5 true JP2022549066A5 (https=) | 2023-09-01 |
Family
ID=75164804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512736A Pending JP2022549066A (ja) | 2019-09-26 | 2020-09-18 | 疾患の処置のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240009191A1 (https=) |
| EP (1) | EP4034109A4 (https=) |
| JP (1) | JP2022549066A (https=) |
| KR (1) | KR20220070435A (https=) |
| CN (1) | CN114466653A (https=) |
| AU (1) | AU2020351826A1 (https=) |
| CA (1) | CA3152115A1 (https=) |
| WO (1) | WO2021056051A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230165838A1 (en) * | 2020-05-06 | 2023-06-01 | Dimerix Bioscience Ltd. | Treatment for acute respiratory distress syndrome |
| WO2021222971A1 (en) * | 2020-05-06 | 2021-11-11 | Dimerix Bioscience Ltd | Treatment for virus induced acute respiratory distress syndrome |
| WO2024026528A1 (en) * | 2022-08-02 | 2024-02-08 | Dimerix Bioscience Pty Ltd | Dosage regimen for the treatment of copd |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2252327A2 (en) * | 2007-12-04 | 2010-11-24 | Schering Corporation | Methods of treating copd |
| US20120100130A1 (en) * | 2009-03-27 | 2012-04-26 | Dimerix Bioscience Pty Ltd. | Novel Receptor Hetero-Dimers/-Oligomers |
| CN107899012A (zh) * | 2011-01-11 | 2018-04-13 | 戴麦里克斯生物科学有限公司 | 联合疗法 |
-
2020
- 2020-09-18 CA CA3152115A patent/CA3152115A1/en active Pending
- 2020-09-18 WO PCT/AU2020/050987 patent/WO2021056051A1/en not_active Ceased
- 2020-09-18 KR KR1020227008648A patent/KR20220070435A/ko not_active Ceased
- 2020-09-18 EP EP20869245.9A patent/EP4034109A4/en not_active Withdrawn
- 2020-09-18 US US17/675,320 patent/US20240009191A1/en not_active Abandoned
- 2020-09-18 CN CN202080067738.3A patent/CN114466653A/zh active Pending
- 2020-09-18 JP JP2022512736A patent/JP2022549066A/ja active Pending
- 2020-09-18 AU AU2020351826A patent/AU2020351826A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8969400B2 (en) | Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound | |
| JP2022549066A5 (https=) | ||
| KR102034703B1 (ko) | 비알코올성 지방성 간 질환 치료제 | |
| JP2022523700A5 (https=) | ||
| JP2013521303A5 (https=) | ||
| JP2011506412A5 (https=) | ||
| CN101031305A (zh) | 类风湿性关节炎的预防和/或治疗药物 | |
| HRP20230210T1 (hr) | Pripravci i postupci upotrebe 2-(4-klorofenil)-n-((2-(2,6-dioksopiperidin-3-il)-1-oksoizoindolin-5-il)metil)-2,2-difluoroacetamida | |
| US20180311236A1 (en) | Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease | |
| JP2012502047A5 (https=) | ||
| JP2022031813A (ja) | １５－ｈｅｐｅを含む組成物、およびそれを用いて線維症を処置または防止する方法 | |
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2022547452A5 (https=) | ||
| TW202342050A (zh) | 用於治療進行性纖維化間質性肺病之新穎治療組合 | |
| JP2020158544A5 (https=) | ||
| CN114984021A (zh) | 用于治疗非酒精性脂肪性肝病的药物组合物及方法 | |
| JPWO2020250915A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2020517704A5 (https=) | ||
| JP2021530488A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| WO2021195521A1 (en) | Methods of treating coronavirus infections | |
| US20220218672A1 (en) | Thromboxane Receptor Antagonists in AERD/Asthma | |
| JP4542777B2 (ja) | 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用 | |
| RU2712281C1 (ru) | Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма | |
| NO334247B1 (no) | Medikament omfattende roflumilast i kombinasjon med formoterol |